TITLE

Helicobacter pylori infection and long term proton pump inhibitor therapy

AUTHOR(S)
McColl K E L
PUB. DATE
January 2004
SOURCE
Gut;Jan2004, Vol. 53 Issue 1, p5
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
12136730

 

Related Articles

  • Are proton pump inhibitors a double-edged sword in the treatment of Helicobacter pylori infection? Ge, Ruiguang // Annals of Gastroenterology;Apr2012, Vol. 25 Issue 2, p87 

    The article offers insights on a study published in this issue of the journal which examined the association between long-term proton pump inhibitor (PPI) therapy and Helicobacter pylori infection. It notes that the study seems to support a positive association between long-term use of PPIs and...

  • TOXICOSIS IN HELICOBACTER PYLORI INFECTION - A HYPOTHESIS. BELASCU, MIHAI // Clujul Medical;2013, Vol. 86 Issue 3, p213 

    Background and aim. We present a new clinical entity in relation to the Helicobacter pylori infection characterized by complex and varied clinical extra-digestive manifestations. Clinical findings such as asthenia, adynamia, sleep disorders, hair and nails modifications, digestive symptoms and...

  • PPIs, H. pylori, and Atrophic Gastritis: Putting the Issue to Rest? DiBaise, John K.; Thompson, Jon S. // American Journal of Gastroenterology;Dec1999, Vol. 94 Issue 12, p3403 

    Discusses research being done on the effect of acid suppression therapy on the development of atrophic gastritis in individuals infected with Helicobacter pylori. Reference to a study by L. Lundell, P. Miettinen, H. E. Myrvold et al., published in the 1999 issue of the "American Journal of...

  • Esomeprazole is a proton pump inhibitor for the management of acid-related disorders.  // Drugs & Therapy Perspectives;Mar2003, Vol. 19 Issue 3, p1 

    Esomeprazole, the S-isomer of omeprazole, is the first proton pump inhibitor (PPI) to be developed as a single optical isomer. Along with other proton pump inhibitors, esomeprazole is an effective option for first-line therapy in the management of acid-related disorders. Esomeprazole is well...

  • Treatment and Post-Treatment Testing for Helicobacter pylori Infection. Howden, Colin W. // Gastroenterology & Hepatology;Nov2012, Vol. 8 Issue 11, p10 

    The article discusses the treatment and post-treatment testing for the infection Helicobacter (H.) pylori. There are various drug regimens used in treating the infection including amoxicillin, clarithromycin, and proton-pump inhibitor. The article also explains that the success rates for H....

  • Results of triple eradication therapy in Japanese children: a retrospective multicenter study. Kato, Seiichi; Konno, Mutsuko; Maisawa, Shun-ichi; Tajiri, Hitoshi; Yoshimura, Norikazu; Shimizu, Toshiaki; Toyoda, Shigeru; Nakayama, Yoshiko; Iinuma, Kazuie // Journal of Gastroenterology;2004, Vol. 39 Issue 9, p838 

    The article presents a study that investigated the efficacy of proton pump inhibitor (PPI)-based triple eradication therapy in Japanese children suffering from Helicobacter pylori infection. Triple therapies consisting of a proton pump inhibitor and two antibiotics have been shown to be...

  • Test and treat for H pylori is 'no better than PPI use'.  // GP: General Practitioner;7/21/2006, p3 

    The article cites a research study conducted by the researchers of Great Britain focusing on the Helicobacter pylori infections. According to the research findings, test and treat for Helicobacter pylori is neither more clinically effective nor more cost-effective than using proton pump...

  • Dual therapy eradicates H pylori, prevents ulcer recurrence.  // Geriatrics;Nov94, Vol. 49 Issue 11, p14 

    Focuses on the eradication of the bacterium Helicobacter pylori through dual therapy with the antibiotic clarithromycin and the proton pump inhibitor omeprazole. Prevention of the recurrence of duodenal ulcers.

  • The Role of Treatment With Proton Pump Inhibitors and Anti-Helicobacter Therapy in Functional Dyspepsia. Van Zanten, S. J. O. Veldhuyzen // American Journal of Gastroenterology;Oct2001, Vol. 96 Issue 10, p2811 

    Focuses on the role of treatment with proton pump inhibitors and anti-Helicobacter therapy in functional dyspepsia. Methodological problems in the design and execution of functional dyspepsia studies; Recommendations for the optimal design of clinical trials of gastrointestinal disorders,...

  • Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy. Gatta, Luigi; Vakil, Nimish; Vaira, Dino; Scarpignato, Carmelo // BMJ: British Medical Journal;8/10/2013, Vol. 347 Issue 7920, p10 

    The article focuses on a study on the meta-analysis of sequential therapy for the global eradication rates for Helicobacter pylori infection. It mentions about the triple treatment therapy which includes the use of a proton pump inhibitor, clarithromycin and amoxicillin or metronidazole. It...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics